Rani Therapeutics Holdings Inc (NAS:RANI)
$ 1.42 0 (0%) Market Cap: 47.30 Mil Enterprise Value: 53.28 Mil PE Ratio: 0 PB Ratio: 13.52 GF Score: 30/100

Rani Therapeutics Holdings Inc at Stifel Healthcare Conference Transcript

Nov 16, 2022 / 02:45PM GMT
Release Date Price: $7.53 (-1.44%)
Annabel Samimy
Stifel Financial Corp. - Analyst

All right. We're going to get started. Thank you very much. Good morning. We're here for the Rani presentation.

I'm Annabel Samimy, biopharmaceutical analyst here at Stifel. And we have CEO, Talat Imran, and CFO, Svai Sanford. Rani is developing, hopefully, what will be the first successful injectable to oral technology for biologics.

So maybe I'll let you introduce the company for a few minutes first, and then we'll just launch into questions.

Talat Imran
Rani Therapeutics Holdings, Inc. - CEO

Absolutely. Annabel, thank you for the time. Thank you for giving us this opportunity and to Stifel as well. I'm going to go through these slides fairly quickly. We're going to make some forward-looking statements. As Annabel mentioned, my name is Talat Imran. I'm the CEO of Rani Therapeutics. I'm joined by Svai Sanford, our CFO.

Rani is a clinical-stage biotech. We're taking injectable biologics and turning them into pills. This is not a new idea. People have been trying to do this for the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot